Hydrochlorothiazide hypertension treatment induced metabolic effects in type 2 diabetes: a meta-analysis of parallel-design RCTs.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  European Review for Medical and Pharmacological Sciences

• Publication date

  2016-07-01

• Fields of study

  Medicine

• Identifiers
  PMID 27424996
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).

  2014cited by this paper
• Nephropathy in diabetes.

  2012cited by this paper
• Candesartan Cilexetil/Hydrochlorothiazide Treatment in High-Risk Patients with Type 2 Diabetes Mellitus and Microalbuminuria

  2012cited by this paper
• Comparison of the efficacy and safety profiles of two fixed-dose combinations of antihypertensive agents, amlodipine/benazepril versus valsartan/hydrochlorothiazide, in patients with type 2 diabetes mellitus and hypertension: a 16-week, multicenter, randomized, double-blind, noninferiority study.

  2012cited by this paper
• Meta-analyses involving cross-over trials: methodological issues.

  2011cited by this paper
• Changes in Serum Potassium Mediate Thiazide-Induced Diabetes

  2010cited by this paper
• Effects of intensive blood-pressure control in type 2 diabetes mellitus.

  2010cited by this paper
• 2010 guidelines of the Taiwan Society of Cardiology for the management of hypertension.

  2010cited by this paper
• Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial.

  2009cited by this paper
• Lack of Correlation Between Thiazide‐Induced Hyperglycemia and Hypokalemia: Subgroup Analysis of Results from the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) Study

  2009cited by this paper
• Executive Summary: Standards of Medical Care in Diabetes—2008

  2008cited by this paper
• Clinical Management of the Metabolic Syndrome

  2008cited by this paper
• Changes in Serum Potassium Mediate Thiazide-Induced Diabetes

  2008cited by this paper
• Effects of Manidipine/Delapril versus Olmesartan/Hydrochlorothiazide Combination Therapy in Elderly Hypertensive Patients with Type 2 Diabetes Mellitus

  2008cited by this paper
• Epilepsy In Children, 2nd Edition

  2005cited by this paper
• Preventive cardiology: abstractVery low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes☆

  2004cited by this paper
• Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004—BHS IV

  2004cited by this paper
• Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.

  2004cited by this paper
• Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: The value randomised trial☆

  2004cited by this paper
• Effect of delapril–manidipine combination vs irbesartan–hydrochlorothiazide combination on fibrinolytic function in hypertensive patients with type II diabetes mellitus

  2004cited by this paper
• Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition

  2004cited by this paper
• Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.

  2003cited by this paper
• A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.

  2003cited by this paper
• Losartan titration versus diuretic combination in type 2 diabetic patients

  2002cited by this paper
• Meta-analyses involving cross-over trials: methodological issues.

  2002cited by this paper
• Quantifying heterogeneity in a meta‐analysis

  2002cited by this paper
• Effect of two antihypertensive combinations on metabolic control in type-2 diabetic hypertensive patients with albuminuria: a randomised, double-blind study

  2001cited by this paper
• THE EFFECT OF NISOLDIPINE AS COMPARED WITH ENALAPRIL ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES AND HYPERTENSION

  2000cited by this paper
• Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

  2000cited by this paper
• The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension.

  1998cited by this paper
• Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis.

  1997cited by this paper
• Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.

  1996cited by this paper
• The effect of enalapril with and without hydrochlorothiazide on insulin sensitivity and other metabolic abnormalities of hypertensive patients with NIDDM.

  1995cited by this paper
• Captopril or conventional therapy in hypertensive type II diabetics. Three-year analysis.

  1993cited by this paper
• Hypertension in Diabetes Study (HDS): I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications.

  1993cited by this paper
• Metabolic considerations in hypertension.

  1990cited by this paper
• Banting lecture 1988. Role of insulin resistance in human disease.

  1988cited by this paper
• Role of Insulin Resistance in Human Disease

  1988cited by this paper
• Meta-analysis in clinical trials.

  1986cited by this paper

• Transport and thiazide-inhibition mechanisms of the Na-Cl cotransporter: a structural perspective

  2025cites this paper
• Pharmacological Nephroprotection in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus—Clinical Practice Position Statement of the Polish Society of Nephrology

  2024cites this paper
• Management of Hypertension in Patients with Type 2 Diabetes Mellitus: Indian Guideline 2024 by Association of Physicians of India and Indian College of Physicians.

  2024cites this paper
• Update on clinical and experimental management of diabetic cardiomyopathy: addressing current and future therapy

  2024cites this paper
• Thiazide-associated hyponatremia increases the risk of major adverse cardiovascular events among elderly Taiwanese patients

  2023cites this paper
• Renal protective effects of natural honey on animal model of hypertension

  2023cites this paper
• A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension.

  2023cites this paper
• American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update.

  2022cites this paper
• Hypertension and Type 2 Diabetes—The Novel Treatment Possibilities

  2022cites this paper
• Discontinuation of low-dose thiazide treatment in hypertensive patients associated with improvement in glycemic profile

  2022cites this paper
• A vérnyomáscsökkentés új fejezete: a tiazidtípusú és a tiazidszerű diuretikumok elkülönítése

  2022cites this paper
• RSSDI Guidelines for the management of hypertension in patients with diabetes mellitus

  2022cites this paper
• Alternativas Terapêuticas ao uso da Hidroclorotiazida em Pacientes Diabéticos e Hipertensos / Therapeutic Alternatives to the use of Hydrochlorothiazide in Diabetic and Hypertensive Pacients

  2021cites this paper
• The Peculiarity of Process and Treatment of Arterial Hypertension in Patients with Type 2 Diabetes Mellitus

  2020cites this paper
• Thiazide Diuretic–Induced Change in Fasting Plasma Glucose: a Meta-analysis of Randomized Clinical Trials

  2020cites this paper
• Searching for optimal blood pressure targets in type 2 diabetic patients with coronary artery disease

  2019cites this paper
• Redefining diuretics use in hypertension: why select a thiazide-like diuretic?

  2019cites this paper
• Type 2 Diabetes and Thiazide Diuretics

  2018cites this paper
• Blood pressure control in type 2 diabetic patients

  2017cites this paper
• Polyphenol epigallocatechin-3-gallate alleviates high glucose-induced H9C2 cell damage through PI3K/Akt pathway.

  2017cites this paper